From: Michael Clarke <[log in to unmask]>
Date: Mon, 29 Jan 2018 14:23:29 +0000

I wonder where the profit margin figures for T&F and Springer Nature come from given these are privately held companies?

 

Of note, last time I checked UVA doesn’t subscribe to T&F’s collection. So the percent of its budget tied up by Big Deal packages would be even larger than half if it included T&F (cited below are only Elsevier, Wiley, Sage, and Springer-Nature).

 

The 16% increase in Elsevier costs is over 5 years, so that is a 4% annual increase, which is not atypical.  

 

For perspective, the $8 million UVA spends on electronic research is a quarter of a percent of the university’s $3.1 billion operating budget, a figure not cited in this presentation nor the summary below.  


 


Date: Sunday, January 28, 2018 at 10:47 PM
To: "[log in to unmask]" <[log in to unmask]>
Subject: Research information costs at the University of Virginia

 

From: Colin Steele <[log in to unmask]>

Date: Sun, Jan 28, 2018 at 7:02 PM


Of interest to the list - Research information costs of the University
of Virginia

power points at:
http://people.virginia.edu/~jmu2m/research.information.costs.uva.pdf

includes the following from the slides-

RESEARCH INFORMATION COSTS AT THE UNIVERSITY OF VIRGINIA
by Brandon Butler and John Unsworth

Presentation to UVA

Electronic resources make up over 80% of our acquisitions budget

• Of that percentage, Elsevier, Wiley, Sage, and Springer-Nature
(primarilynSTEM content) consume more than half.

• Their slice of our collections budget has doubled in less than a
decade – from 21% in 2009 to 43% today.

• Electronic subscriptions consume 100% of our state funding; all
otherbresources have been acquired using local funds for the past
several years, and those funds are not replenishing fast enough to
support appropriate collection-building.

E-licensing costs projected to grow 33% overall, And there are
important research resources that we don’t have access to, already

• Total spend on e-resources will grow from ~$8mil to ~$10.7mil

• Elsevier deal alone grows 16% over this time, a contractual
ncommitment we cannot change

Publisher Profit Margins Rival Apple, Big Pharma

• Pharmaceuticals (Pfizer): 42%
• RELX (Elsevier): 39%
• Apple: 37%
• Taylor & Francis: 36%
• Springer-Nature: 35%
• Banking (Industrial & Commercial Bank of China): 29%
• Wiley: 28%

---------------------------------------------

Colin Steele
Emeritus Fellow
ANU College of Arts and Social Sciences
The Australian National University
Room 3.31, Beryl Rawson Building #13
Acton, ACT, 2601
Australia

P:
+ 61 2 6125 8983
E:
[log in to unmask]